Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients

Clinical Endocrinology

Volumn 70, Issue 3, 2009, Pages 401-407

  Ezzidi, Intissar ^b   Mtiraoui, Nabil ^b   Kacem, Maha ^c   Mallat, Samir G ^d   Mohamed, Manel Ben Hadj ^b   Chaieb, Molka ^c   Mahjoub, Touhami ^b   Almawi, Wassim Y ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c Nephrology and Internal Medicine Service EPS F Bourguiba   (Tunisia)

^d SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUNISIA;

EID: 60349101062     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03337.x     Document Type: Article

References (34)

1. Gross, J.L., de Azevedo, M.J., Silveiro, S.P. et al. (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care, 28, 164 176.
2. Wu, A.Y., Kong, N.C., de Leon, F.A. et al. (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia, 48, 17 26.
3. Agius, E., Attard, G., Shakespeare, L. et al. (2006) Familial factors in diabetic nephropathy: an offspring study. Diabetic Medicine, 23, 331 334.
4. Kolb, H. Mandrup-Poulsen, T. (2005) An immune origin of type 2 diabetes? Diabetologia, 48, 1038 1050.
5. Pickup, J.C. (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27, 813 823.
6. Pradhan, A.D., Manson, J.E., Rifai, N. et al. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of American Medical Association, 286, 327 334.
7. Pickup, J.C., Mattock, M.B., Chusney, G.D. et al. (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome-X. Diabetologia, 40, 1286 1292.
8. Hink, U., Li, H., Mollnau, H. et al. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research, 88, E14 E22.
9. Viardot, A., Grey, S.T., Mackay, F. et al. (2007) Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology, 148, 346 353.
10. van Exel, E., Gussekloo, J., de Craen, A.J. et al. (2002) Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes, 51, 1088 1092.
11. Lalani, I., Bhol, K. Ahmed, A.R. (1997) Interleukin-10: biology, role in inflammation and autoimmunity. Annals of Allergy, Asthma and Immunology, 79, 469 483.
12. Temple, S.E., Lim, E., Cheong, K.Y. et al. (2003) Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics, 55, 629 632.
13. Kilpinen, S., Huhtala, H. Hurme, M. (2002) The combination of the interleukin-1α (IL-1α-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals. European Cytokine Network, 13, 66 71.
14. Mora, C. Navarro, J.F. (2005) The role of inflammation as a pathogenic factor in the development of renal disease in diabetes. Current Diabetes Reports, 5, 399 401.
15. Tuttle, K.R. (2005) Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. Journal of the American Society of Nephrology, 16, 1537 1538.
16. Wong, C.K., Ho, A.W., Tong, P.C. et al. (2007) Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clinical and Experimental Immunology, 149, 123 131.
17. Zamauskaite, A., Yaqoob, M.M., Madrigal, J.A. et al. (1999) The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy. European Cytokine Network, 10, 219 226.
18. Mysliwska, J., Zorena, K., Semetkowska-Jurkiewicz, E. et al. (2005) High levels of circulating interleukin-10 in diabetic nephropathy patients. European Cytokine Network, 16, 117 122.
19. Karhukorpi, J., Laitinen, T., Karttunen, R. et al. (2001) The functionally important IL-10 promoter polymorphism (-1082G→A) is not a major genetic regulator in recurrent spontaneous abortions. Molecular Human Reproduction, 7, 201 203.
20. Schena, F.P. Gesualdo, L. (2005) Pathogenetic mechanisms of diabetic nephropathy. Journal of the American Society of Nephrology, 16 (Suppl. 1 S30 S33.
21. Galkina, E. Ley, K. (2006) Leukocyte recruitment and vascular injury in diabetic nephropathy. Journal of the American Society of Nephrology, 17, 368 377.
22. Dalla Vestra, M., Mussap, M., Gallina, P. et al. (2005) Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. Journal of the American Society of Nephrology, 16 (Suppl. 1 S78 S82.
23. Navarro, J.F., Mora, C., Maca, M. et al. (2003) Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases, 42, 53 61.
24. Kelly, D.J., Zhang, Y., Hepper, C. et al. (2003) Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes, 52, 512 518.
25. Tuttle, K.R., Bakris, G.L., Toto, R.D. et al. (2005) The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care, 28, 2686 2690.
26. Crawley, E., Woo, P. Isenberg, D.A. (1999) Single nucleotide polymorphic haplotypes of the interleukin-10 5′ flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis and Rheumatism, 42, 2017 2018.
27. Babel, N., Gabdrakhmanova, L., Hammer, M.H. et al. (2006) Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. Journal of Nephrology, 19, 802 807.
28. Hoffmann, S.C., Stanley, E.M., Cox, E.D. et al. (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation, 2, 560 567.
29. Keijsers, V., Verweij, C.L., Westendorp, R.G.J. et al. (1997) IL10 polymorphisms in relation to production and rheumatoid arthritis (Abstract). Arthritis and Rheumatism, 40 (Suppl. 9 S179.
30. Kahraman, S., Yilmaz, R., Arici, M. et al. (2006) IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. Journal of Nephrology, 19, 50 56.
31. Zhu, L.J., Liu, Z.H., Zeng, C.H. et al. (2005) Association of interleukin-10 gene -592 A/C polymorphism with the clinical and pathological diversity of lupus nephritis. Clinical and Experimental Rheumatology, 23, 854 860.
32. Wu, H.C., Ling, H., Na, S.P. et al. (2005) Interleukin-10 genotype protects end stage renal disease patients from microinflammation and arteriosclerosis. Chinese Medical Journal, 118, 1549 1551.
33. Bantis, C., Heering, P.J., Aker, S. et al. (2004) Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney International, 66, 288 294.
34. George, S., Ruan, X.Z., Navarrete, C. et al. (2004) Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens, 63, 470 475.